This is Kevin; today is Wednesday, August 4. On today’s podcast I’m speaking with our EB physicians Doc Andrews and Doc Hurley.
Thank you both for joining the podcast. As physicians, you have been on the front lines managing this pandemic. You are resources we’ve grown to trust for the simple truths on getting through this.
There’s been a lot of confusion in the last couple of weeks with the spread of the delta variant of COVID. In my podcast on Monday I emphasized the importance of vaccines in controlling this pandemic. Some people are hesitating to get vaccinated because they think the vaccines were developed quickly and are, therefore, experimental. The technology behind the Pfizer and Moderna mRNA vaccines is new, but not unknown. Let’s talk about that as well as the technology behind the J&J viral vector vaccine.
Dr. Andrews: There is a lot of material on the CDC and the public health websites explaining how the vaccines work, sometimes I’d say there’s even too much material. So I will try to simplify the information. Let’s start with the mRNA vaccines that teach our cells how to make proteins that trigger an immune response inside our bodies. This immune response produces antibodies which are the items that actually protect us from getting infected if the real virus enters our bodies.
The mRNA vaccines trigger our cells to produce a harmless protein, called the spike protein. The spike protein is also located on the surface of the COVID virus. Our cells display the spike protein, then our immune response recognizes that the protein does not belong there and begins building an immune response with antibodies.
In this way we have taught our cells to identify and fight the COVID virus.
Alternatively, vector vaccines like the J&J vaccine contain a modified version of a different virus than COVID-19. Inside the shell of the modified version is a piece of material from COVID-19. This unit is called the viral vector. Once the viral vector is inside our cells (and I mean that to be not the COVID-19 virus), then our cells make copies of the unique protein. Our T and B lymphocytes will remember this unique protein and fight it if we are infected in the future.
The biggest difference in the two vaccines is the first stage of the immune response. One relies on mRNA while the other relies on a vector to start the process of building spike proteins that will trigger our immune system to produce antibodies that ultimately recognize if COVID-19 enters our body.
It is also important to remember that just because the vaccines were developed fast, no steps were skipped in the process of making them.
Thanks Doc Andrews, appreciate that explanation. The media has been focusing on breakthrough infections among the vaccinated with this delta variant of COVID. How rare are breakthrough infections, and when they do occur, how sick do people get, generally?
Dr. Hurley: A breakthrough case means that someone who has been fully vaccinated and has waited two weeks to develop full immunity still contracts COVID-19. Breakthrough infections are actually expected. While the vaccines have proven highly effective against the virus, even for new variants like the delta, they do not offer perfect protection. That’s one of the reasons why the Centers for Disease Control and Prevention last week revised its guidance and recommended that in places with high rates of transmission such as Oklahoma, even vaccinated people should wear masks in public indoor settings.
The good news is that vaccines have been found to be extremely good at preventing serious illness and death. Of those hospitalized with the virus, more than 97% are the unvaccinated. The CDC estimates that for every 102,000 vaccinated individuals, only 100 end up hospitalized, and only one will die. While those numbers are not perfect, they are very, very good.
If vaccinated people come down with infections, the vast majority will be asymptomatic or mild. Nonetheless, they may still be able to spread the virus to others before their immune system, which has been primed by the vaccine, stamps it out. Preliminary data suggest that when people do get breakthrough infections, they carry a high amount of the virus for at least one week.
As with the original strain of the coronavirus, dose seems to matter with the delta variant. The higher the load of viral exposure—think of a brief masked encounter versus spending hours and hours unmasked in a room with an infected person—with the high viral exposures, the more likely immune defenses will become overwhelmed and result in a symptomatic or serious infection.
Currently the data shows that with 163 million people in the US fully vaccinated, you can expect up to about 125,000-and-change breakthrough cases. The data is still coming in, and this number can be found as low as 7,000 and beyond 125,000, and this is as of July 30. What it translates to is about .08% or one in every 1,300 cases will become a breakthrough case. The CDC has developed a national vaccine breakthrough reporting database so that more information can help us determine what the true rate is.
Remember—the bottom line is that vaccination prevents severe illness, hospitalizations, and death.
Thanks Doc Hurley. Some people might also hesitate to get vaccinated because the current vaccines have emergency use authorizations rather than the full FDA approval. Let’s talk about the amount of safety and efficacy data that’s been generated so far through the administration of these vaccines.
Dr. Hurley: Full FDA approval is an important milestone. A number of universities and hospitals, the Defense Department and at least one major city, San Francisco, are expected to mandate inoculation once a vaccine is fully FDA approved. Final approval could also help mute misinformation circulating on the internet about the safety of vaccines and also clarify the legal issues some have raised in order to thwart public health mandates.
Pfizer filed its application on May 7, 2021. With a new surge of COVID-19 infections, the Food and Drug Administration has accelerated its timetable to fully approve Pfizer-BioNTech’s coronavirus vaccine, aiming to complete the process by the start of next month. The White House has set a time line of prior to Labor Day.
Moderna, the second most widely used vaccine in the United States, filed for final approval of its vaccine on June 1, 2021. But the company is still submitting data and has not said when it will finish.
Johnson & Johnson, the third vaccine authorized for emergency use, has not yet applied but plans to do so later this year.
Dr. Andrews: In regards to safety, over 342 million doses of the COVID vaccine have been given in the US. Prior to emergency use authorization or EUA approval, tens of thousands of people were studied in clinical trials. Since the original trials, millions of more people have been vaccinated, just demonstrating how safe and effective they really are.
The three well publicized and serious, but rare safety problems are anaphylaxis, which is a severe allergic reaction. This usually occurs within 30 minutes of administration of any of the vaccine at a rate of two per million. The second is thrombosis with thrombocytopenia syndrome; this was mostly with the J&J vaccine at a rate of seven per one million, and it was in women between 18 to 49 years old and was even less often for men and women over 50 years old. Third is myocarditis and pericarditis with 1,194 cases reported of which only 699 have been confirmed so far.
So again, the benefits from the vaccine of decreasing your risk of severe illness, hospitalization, and death far outweigh the risks of the vaccines themselves.
So bottom line, the vaccines are safe and effective. Now, they are also readily available. How can our folks access the vaccine through our EB channels?
Dr. Andrews: First, all states have vaccine readily available through dept. of public health and private sector pharmacies such as Walgreens, CVS and even Walmart.
In Connecticut, the Yard Hospital and EB Family Pharmacy have vaccines. The Yard Hospital has a supply of Moderna and several J+J vaccines. Our Groton EB Pharmacy has the Pfizer vaccine. In Rhode Island, the EB Family Pharmacy has vaccines as well.
Both pharmacies, the Yard Hospital, Dispensary, and Wellness Center also would be happy to answer questions or direct you and your family to community vaccination sites if you prefer that route.
The recent spread of the delta variant, and the communication around it, has been confusing, frustrating, and fluid, but that’s actually irrelevant. What’s true about managing this virus has not changed—people need to get vaccinated. If you’re sick, stay home. Wash your hands frequently and try to be outside as much as possible. Those not yet vaccinated should wear a mask outdoors when they are in a crowd, at a large event, or in a public place where keeping their distance from others is difficult, and must wear a mask indoors at all times.
Docs, thank you for taking the time to talk about COVID vaccines and COVID again. Our highest priority at Electric Boat is safety, and the best way to ensure you’re safe from COVID, meaning you don’t die or get sick from it, is to please get vaccinated.
Thanks everybody; we’ll talk again soon.
Electric Boat featured in latest episode of ‘Cast in Steel’
General Dynamics Electric Boat is featured in the latest episode of Cast in Steel, a web series that showcases the leaders of America’s steel industry as part of their competition to promote careers in metalworking. The Cast in Steel team visited our Quonset Point facility to highlight how EB’s shipbuilders transform flat steel into nuclear...Continue reading→
EB’s Groton Shipyard Celebrates 100 Years of Submarine Construction
The first submarine ever built in Electric Boat’s Groton shipyard slid gracefully from its ways into the Thames River 100 years ago, taking to the water with “scarcely a splash” before a crowd of 1,500, according to newspaper accounts at the time. A century after the 800-ton, 200-foot-long R2 was launched, EB shipbuilders continue to...Continue reading→
President Trump Gives Our Submarines a Shoutout at Pennsylvania Innovation and Defense Summit
During his remarks at the Pennsylvania Innovation and Defense Summit held on July 15 at the U.S. Army War College in Carlisle, PA, President Donald Trump introduced attendee Danny Deep, president of General Dynamics. In his quick words to Danny, President Trump recognized General Dynamics for building “the greatest submarines in the world.” Continue reading→
Rayha Report Ep. 23: Matt Olander Honored by UConn College of Engineering
In this episode of the Rayha Report, EB President Mark Rayha speaks with Matt Olander, senior vice president of programs and engineering, about his personal career journey and recent return to UConn’s College of Engineering as an honorary degree recipient and 2026 commencement speaker. Watch Matt’s commencement speech on the UConn College of Engineering YouTube channel.Continue reading→
Rayha Report Ep. 22: Run to Home Base 2026
In his latest Rayha Report, EB President Mark Rayha talks with Run to Home Base co-chair Tammee Sweck and runners Amy and Greyson Stephenson about why this annual fundraiser means so much to our veterans, service members, and their families. Learn how Team General Dynamics is preparing for the July 25 event at Fenway Park...Continue reading→
Rayha Report Ep. 21: Backstage With Chris Stapleton
In the latest Rayha Report, EB President Mark Rayha hit the road for a backstage chat with American singer-songwriter and guitarist Chris Stapleton. Chris is not only an extraordinary artist, but someone whose values resonate deeply with the people of Electric Boat: pride in craftsmanship, respect for hard work and a genuine love for this...Continue reading→
Happy Fourth of July
As America marks its 250th birthday, we celebrate the generations of shipbuilders whose skill and commitment have strengthened our nation, and especially thank our current generation of EB shipbuilders for all you’re doing to meet this challenging moment in history. Happy Fourth of July.
Electric Boat and SENEDIA Celebrate 10,000-Graduate Milestone
We are proud to recognize a major workforce milestone with the Southeastern New England Defense Industry Alliance (SENEDIA), one of Electric Boat’s key training and workforce development partners. At an event on July 1, 2026, held at the Westerly Education Center, SENEDIA celebrated the 10,000th graduate to complete the New England Submarine Shipbuilding Partnership—a regional...Continue reading→
Safety Update: Installation of Speed Tables on Eastern Point Road
In an effort to increase safety at Electric Boat’s Groton shipyard, two speed tables are being installed across Eastern Point Road this week. The tables, a few inches tall and marked with yellow stripes, are designed to slow vehicle traffic in an area frequented by pedestrians. The first speed table crosses Eastern Point Road just...Continue reading→
EB firefighters recognized for life-saving rescues
Five members of the Electric Boat Fire Department in Groton were recognized for perilous, life-saving rescues during a pair of multi-alarm fires that engulfed apartments in Groton and New London in 2025. Firefighters Thomas Gugliotti, Arthur Keaten, Theodore Bartkoski, James Brady and Capt. Ryan Boulanger were each presented with Lifesaving Awards and the prestigious 2026...Continue reading→
